SOME RELATED FACTORS OF RENAL FUNCTION CHANGES ON DIABETE TYPE 2 PATIENTS WHO ARE OUTPATIENT TREATMENT IN SAINT PAUL GENERAL HOSPITAL 2022
About this article
Received: 17/10/22                Revised: 07/12/22                Published: 20/12/22Abstract
Keywords
Full Text:
PDF (Tiếng Việt)References
[1] Ministry of Health, Guidelines of diagnostic and therapeutic type 2 diabetes promulgated with the decision No 3319/QĐ-BYT on dated 19/07/2017, 2017.
[2] C. Rask-Madsen and G. L. King, “Kidney complications: factors that protect the diabetic vasculature,” Nature medicine, vol. 16, no. 1, pp. 40-41, 2010.
[3] R. Z. Alicic, M. T. Rooney, and K. R. Tuttle, “Diabetic kidney disease: challenges, progress, and possibilities,” Clinical journal of the American Society of Nephrology, vol. 12, no. 12, pp. 2032-2045, 2017.
[4] T. T. H. Tran, V. K. Tran, T. V. H. Dang, T. A. Nguyen, and Q. H. Nguyen, “Research on the relation between AGT M235T genotypic polymorphism and diabete kidney disease”, Journal of medical research, vol. 137, no.1, pp. 58-65, 2021.
[5] J. L. Gross, M. J. De Azevedo, S. P. Silveiro, L. H. Canani et al., “Diabetic nephropathy: diagnosis, prevention, and treatment,” Diabetes care, vol. 28, no.1, pp. 164-176, 2005.
[6] T. T. N. Nguyen, T. V. Hoang, and T. B. D. Nguyen, “Change of insulin resistance, stage of damage before and after treatment of type 2 diabetes with impaired kidney function”, Vietnam association of diabetes and endocrinology, no. 13, pp. 47-51, 2014.
[7] R. J. Macissae and G. Jerums, “Diabetic kidney disease with and without albuminuria,” Curr Opin Neprol Hypertens, vol. 20, no. 3, pp. 246-257, 2011.
[8] J. A. Jefferson, S. J. Shankland, and R. H. Pichler, “Proteinuria in diabetic kidney disease: a mechanistic viewpoint,” Kidney international, vol. 74, no. 1, pp. 22-36, 2008.
[9] Ministry of Health, Guidelines of diagnostic and therapeutic type 2 diabetes promulgated with the decision No 5481/QĐ-BYT on dated 31/12/2020, 2020.
[10] A. Y. Wu, N. C. Kong, F. A. De Leon et al., “An alermingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study,” Diabetologia, vol. 48, no. 1, pp. 17-26, 2005.
[11] V. B. Ta, Prevention and management diabetes in Vietnam, Medical Publishing House, 2004.
[12] P. Rein, A. Vonbank, C. Sealy et al., “Relation of albuminuria to angiopraphycally determined coronary arterial narrowing in patient with and without diabetes mellitus and stable or suspected coronary artery disease,” Am J Cardiol, vol. 107, no. 8, pp. 1144-1148, 2011.DOI: https://doi.org/10.34238/tnu-jst.6686
Refbacks
- There are currently no refbacks.





